Wild-Type IDH1 Maintains NSCLC Stemness and Chemoresistance through Activation of the Serine Biosynthetic Pathway

Researchers reported that wild-type isocitrate dehydrogenase 1 (IDH1) activated serine biosynthesis by enhancing the expression of phosphoglycerate dehydrogenase and phosphoserine aminotransferase 1.